Details for New Drug Application (NDA): 050757
✉ Email this page to a colleague
NDA 050757 describes PREVPAC (COPACKAGED), which is a drug marketed by Takeda Pharms Usa and is included in one NDA. Additional details are available on the PREVPAC (COPACKAGED) profile page.
The generic ingredient in PREVPAC (COPACKAGED) is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
The generic ingredient in PREVPAC (COPACKAGED) is amoxicillin; clarithromycin; lansoprazole. There are forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amoxicillin; clarithromycin; lansoprazole profile page.
Summary for 050757
| Tradename: | PREVPAC (COPACKAGED) |
| Applicant: | Takeda Pharms Usa |
| Ingredient: | amoxicillin; clarithromycin; lansoprazole |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 500MG;500MG;30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Dec 2, 1997 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 050757
Complete Access Available with Subscription
